Pharma & Healthcare
Global HER2 ADC Drugs Market Research Report 2026
- Mar 17, 26
- ID: 738604
- Pages: 114
- Figures: 109
- Views: 7
This report delivers a comprehensive overview of the global HER2 ADC Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HER2 ADC Drugs. The HER2 ADC Drugs market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global HER2 ADC Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist HER2 ADC Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Daiichi Sankyo
Genentech, Inc.(Roche)
AstraZeneca
RemeGen
MacroGenics
Takeda
Biokin Pharmaceutical
BioNTech(Yingen Biopharmaceutical)
CSPC Pharmaceutical Group
Hengrui Pharmaceuticals
Segment by Type
T-DM1（Kadcyla，Trastuzumab emtansine）
T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
RC48（Disitamab vedotin）
by Application
Hospitals
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for HER2 ADC Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines HER2 ADC Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global HER2 ADC Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist HER2 ADC Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Daiichi Sankyo
Genentech, Inc.(Roche)
AstraZeneca
RemeGen
MacroGenics
Takeda
Biokin Pharmaceutical
BioNTech(Yingen Biopharmaceutical)
CSPC Pharmaceutical Group
Hengrui Pharmaceuticals
Segment by Type
T-DM1（Kadcyla，Trastuzumab emtansine）
T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
RC48（Disitamab vedotin）
by Application
Hospitals
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for HER2 ADC Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines HER2 ADC Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 HER2 ADC Drugs Market Overview
1.1 Product Definition
1.2 HER2 ADC Drugs by Type
1.2.1 Global HER2 ADC Drugs Market Value by Type: 2025 vs 2032
1.2.2 T-DM1（Kadcyla，Trastuzumab emtansine）
1.2.3 T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
1.2.4 RC48（Disitamab vedotin）
1.3 HER2 ADC Drugs by Application
1.3.1 Global HER2 ADC Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global HER2 ADC Drugs Market Size Estimates and Forecasts
1.4.1 Global HER2 ADC Drugs Revenue 2021–2032
1.4.2 Global HER2 ADC Drugs Sales 2021–2032
1.4.3 Global HER2 ADC Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 HER2 ADC Drugs Market Competition by Manufacturers
2.1 Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global HER2 ADC Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of HER2 ADC Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of HER2 ADC Drugs, Product Types and Applications
2.7 Global Key Manufacturers of HER2 ADC Drugs, Date of Entry into the Industry
2.8 Global HER2 ADC Drugs Market Competitive Situation and Trends
2.8.1 Global HER2 ADC Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global HER2 ADC Drugs Players Market Share by Revenue
2.8.3 Global HER2 ADC Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 ADC Drugs Market Scenario by Region
3.1 Global HER2 ADC Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global HER2 ADC Drugs Sales by Region: 2021–2032
3.2.1 Global HER2 ADC Drugs Sales by Region: 2021–2026
3.2.2 Global HER2 ADC Drugs Sales by Region: 2027–2032
3.3 Global HER2 ADC Drugs Revenue by Region: 2021–2032
3.3.1 Global HER2 ADC Drugs Revenue by Region: 2021–2026
3.3.2 Global HER2 ADC Drugs Revenue by Region: 2027–2032
3.4 North America HER2 ADC Drugs Market Facts & Figures by Country
3.4.1 North America HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America HER2 ADC Drugs Sales by Country (2021–2032)
3.4.3 North America HER2 ADC Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 ADC Drugs Market Facts & Figures by Country
3.5.1 Europe HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe HER2 ADC Drugs Sales by Country (2021–2032)
3.5.3 Europe HER2 ADC Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 ADC Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 ADC Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific HER2 ADC Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific HER2 ADC Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 ADC Drugs Market Facts & Figures by Country
3.7.1 Latin America HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America HER2 ADC Drugs Sales by Country (2021–2032)
3.7.3 Latin America HER2 ADC Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HER2 ADC Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa HER2 ADC Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa HER2 ADC Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 ADC Drugs Sales by Type (2021–2032)
4.1.1 Global HER2 ADC Drugs Sales by Type (2021–2026)
4.1.2 Global HER2 ADC Drugs Sales by Type (2027–2032)
4.1.3 Global HER2 ADC Drugs Sales Market Share by Type (2021–2032)
4.2 Global HER2 ADC Drugs Revenue by Type (2021–2032)
4.2.1 Global HER2 ADC Drugs Revenue by Type (2021–2026)
4.2.2 Global HER2 ADC Drugs Revenue by Type (2027–2032)
4.2.3 Global HER2 ADC Drugs Revenue Market Share by Type (2021–2032)
4.3 Global HER2 ADC Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global HER2 ADC Drugs Sales by Application (2021–2032)
5.1.1 Global HER2 ADC Drugs Sales by Application (2021–2026)
5.1.2 Global HER2 ADC Drugs Sales by Application (2027–2032)
5.1.3 Global HER2 ADC Drugs Sales Market Share by Application (2021–2032)
5.2 Global HER2 ADC Drugs Revenue by Application (2021–2032)
5.2.1 Global HER2 ADC Drugs Revenue by Application (2021–2026)
5.2.2 Global HER2 ADC Drugs Revenue by Application (2027–2032)
5.2.3 Global HER2 ADC Drugs Revenue Market Share by Application (2021–2032)
5.3 Global HER2 ADC Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Genentech, Inc.(Roche)
6.2.1 Genentech, Inc.(Roche) Company Information
6.2.2 Genentech, Inc.(Roche) Description and Business Overview
6.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
6.2.5 Genentech, Inc.(Roche) Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AstraZeneca HER2 ADC Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 RemeGen
6.4.1 RemeGen Company Information
6.4.2 RemeGen Description and Business Overview
6.4.3 RemeGen HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 RemeGen HER2 ADC Drugs Product Portfolio
6.4.5 RemeGen Recent Developments/Updates
6.5 MacroGenics
6.5.1 MacroGenics Company Information
6.5.2 MacroGenics Description and Business Overview
6.5.3 MacroGenics HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MacroGenics HER2 ADC Drugs Product Portfolio
6.5.5 MacroGenics Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Takeda HER2 ADC Drugs Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 Biokin Pharmaceutical
6.7.1 Biokin Pharmaceutical Company Information
6.7.2 Biokin Pharmaceutical Description and Business Overview
6.7.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
6.7.5 Biokin Pharmaceutical Recent Developments/Updates
6.8 BioNTech(Yingen Biopharmaceutical)
6.8.1 BioNTech(Yingen Biopharmaceutical) Company Information
6.8.2 BioNTech(Yingen Biopharmaceutical) Description and Business Overview
6.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
6.8.5 BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
6.9 CSPC Pharmaceutical Group
6.9.1 CSPC Pharmaceutical Group Company Information
6.9.2 CSPC Pharmaceutical Group Description and Business Overview
6.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
6.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Company Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 ADC Drugs Industry Chain Analysis
7.2 HER2 ADC Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 ADC Drugs Production Mode & Process Analysis
7.4 HER2 ADC Drugs Sales and Marketing
7.4.1 HER2 ADC Drugs Sales Channels
7.4.2 HER2 ADC Drugs Distributors
7.5 HER2 ADC Drugs Customer Analysis
8 HER2 ADC Drugs Market Dynamics
8.1 HER2 ADC Drugs Industry Trends
8.2 HER2 ADC Drugs Market Drivers
8.3 HER2 ADC Drugs Market Challenges
8.4 HER2 ADC Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 HER2 ADC Drugs by Type
1.2.1 Global HER2 ADC Drugs Market Value by Type: 2025 vs 2032
1.2.2 T-DM1（Kadcyla，Trastuzumab emtansine）
1.2.3 T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
1.2.4 RC48（Disitamab vedotin）
1.3 HER2 ADC Drugs by Application
1.3.1 Global HER2 ADC Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global HER2 ADC Drugs Market Size Estimates and Forecasts
1.4.1 Global HER2 ADC Drugs Revenue 2021–2032
1.4.2 Global HER2 ADC Drugs Sales 2021–2032
1.4.3 Global HER2 ADC Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 HER2 ADC Drugs Market Competition by Manufacturers
2.1 Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global HER2 ADC Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of HER2 ADC Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of HER2 ADC Drugs, Product Types and Applications
2.7 Global Key Manufacturers of HER2 ADC Drugs, Date of Entry into the Industry
2.8 Global HER2 ADC Drugs Market Competitive Situation and Trends
2.8.1 Global HER2 ADC Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global HER2 ADC Drugs Players Market Share by Revenue
2.8.3 Global HER2 ADC Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 ADC Drugs Market Scenario by Region
3.1 Global HER2 ADC Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global HER2 ADC Drugs Sales by Region: 2021–2032
3.2.1 Global HER2 ADC Drugs Sales by Region: 2021–2026
3.2.2 Global HER2 ADC Drugs Sales by Region: 2027–2032
3.3 Global HER2 ADC Drugs Revenue by Region: 2021–2032
3.3.1 Global HER2 ADC Drugs Revenue by Region: 2021–2026
3.3.2 Global HER2 ADC Drugs Revenue by Region: 2027–2032
3.4 North America HER2 ADC Drugs Market Facts & Figures by Country
3.4.1 North America HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America HER2 ADC Drugs Sales by Country (2021–2032)
3.4.3 North America HER2 ADC Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 ADC Drugs Market Facts & Figures by Country
3.5.1 Europe HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe HER2 ADC Drugs Sales by Country (2021–2032)
3.5.3 Europe HER2 ADC Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 ADC Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 ADC Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific HER2 ADC Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific HER2 ADC Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 ADC Drugs Market Facts & Figures by Country
3.7.1 Latin America HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America HER2 ADC Drugs Sales by Country (2021–2032)
3.7.3 Latin America HER2 ADC Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HER2 ADC Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 ADC Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa HER2 ADC Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa HER2 ADC Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 ADC Drugs Sales by Type (2021–2032)
4.1.1 Global HER2 ADC Drugs Sales by Type (2021–2026)
4.1.2 Global HER2 ADC Drugs Sales by Type (2027–2032)
4.1.3 Global HER2 ADC Drugs Sales Market Share by Type (2021–2032)
4.2 Global HER2 ADC Drugs Revenue by Type (2021–2032)
4.2.1 Global HER2 ADC Drugs Revenue by Type (2021–2026)
4.2.2 Global HER2 ADC Drugs Revenue by Type (2027–2032)
4.2.3 Global HER2 ADC Drugs Revenue Market Share by Type (2021–2032)
4.3 Global HER2 ADC Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global HER2 ADC Drugs Sales by Application (2021–2032)
5.1.1 Global HER2 ADC Drugs Sales by Application (2021–2026)
5.1.2 Global HER2 ADC Drugs Sales by Application (2027–2032)
5.1.3 Global HER2 ADC Drugs Sales Market Share by Application (2021–2032)
5.2 Global HER2 ADC Drugs Revenue by Application (2021–2032)
5.2.1 Global HER2 ADC Drugs Revenue by Application (2021–2026)
5.2.2 Global HER2 ADC Drugs Revenue by Application (2027–2032)
5.2.3 Global HER2 ADC Drugs Revenue Market Share by Application (2021–2032)
5.3 Global HER2 ADC Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Genentech, Inc.(Roche)
6.2.1 Genentech, Inc.(Roche) Company Information
6.2.2 Genentech, Inc.(Roche) Description and Business Overview
6.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
6.2.5 Genentech, Inc.(Roche) Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AstraZeneca HER2 ADC Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 RemeGen
6.4.1 RemeGen Company Information
6.4.2 RemeGen Description and Business Overview
6.4.3 RemeGen HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 RemeGen HER2 ADC Drugs Product Portfolio
6.4.5 RemeGen Recent Developments/Updates
6.5 MacroGenics
6.5.1 MacroGenics Company Information
6.5.2 MacroGenics Description and Business Overview
6.5.3 MacroGenics HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MacroGenics HER2 ADC Drugs Product Portfolio
6.5.5 MacroGenics Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Takeda HER2 ADC Drugs Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 Biokin Pharmaceutical
6.7.1 Biokin Pharmaceutical Company Information
6.7.2 Biokin Pharmaceutical Description and Business Overview
6.7.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
6.7.5 Biokin Pharmaceutical Recent Developments/Updates
6.8 BioNTech(Yingen Biopharmaceutical)
6.8.1 BioNTech(Yingen Biopharmaceutical) Company Information
6.8.2 BioNTech(Yingen Biopharmaceutical) Description and Business Overview
6.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
6.8.5 BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
6.9 CSPC Pharmaceutical Group
6.9.1 CSPC Pharmaceutical Group Company Information
6.9.2 CSPC Pharmaceutical Group Description and Business Overview
6.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
6.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Company Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 ADC Drugs Industry Chain Analysis
7.2 HER2 ADC Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 ADC Drugs Production Mode & Process Analysis
7.4 HER2 ADC Drugs Sales and Marketing
7.4.1 HER2 ADC Drugs Sales Channels
7.4.2 HER2 ADC Drugs Distributors
7.5 HER2 ADC Drugs Customer Analysis
8 HER2 ADC Drugs Market Dynamics
8.1 HER2 ADC Drugs Industry Trends
8.2 HER2 ADC Drugs Market Drivers
8.3 HER2 ADC Drugs Market Challenges
8.4 HER2 ADC Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global HER2 ADC Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global HER2 ADC Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global HER2 ADC Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global HER2 ADC Drugs Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global HER2 ADC Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global HER2 ADC Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market HER2 ADC Drugs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of HER2 ADC Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of HER2 ADC Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of HER2 ADC Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HER2 ADC Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on HER2 ADC Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global HER2 ADC Drugs Sales by Region (kg), 2021–2026
Table 18. Global HER2 ADC Drugs Sales Market Share by Region (2021–2026)
Table 19. Global HER2 ADC Drugs Sales by Region (kg), 2027–2032
Table 20. Global HER2 ADC Drugs Sales Market Share by Region (2027–2032)
Table 21. Global HER2 ADC Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global HER2 ADC Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global HER2 ADC Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global HER2 ADC Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 27. North America HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 28. North America HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 32. Europe HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 33. Europe HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific HER2 ADC Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific HER2 ADC Drugs Sales by Region (kg), 2021–2026
Table 37. Asia Pacific HER2 ADC Drugs Sales by Region (kg), 2027–2032
Table 38. Asia Pacific HER2 ADC Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific HER2 ADC Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 42. Latin America HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 43. Latin America HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global HER2 ADC Drugs Sales (kg) by Type (2021–2026)
Table 51. Global HER2 ADC Drugs Sales (kg) by Type (2027–2032)
Table 52. Global HER2 ADC Drugs Sales Market Share by Type (2021–2026)
Table 53. Global HER2 ADC Drugs Sales Market Share by Type (2027–2032)
Table 54. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global HER2 ADC Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global HER2 ADC Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global HER2 ADC Drugs Price (US$/kg) by Type (2021–2026)
Table 59. Global HER2 ADC Drugs Price (US$/kg) by Type (2027–2032)
Table 60. Global HER2 ADC Drugs Sales (kg) by Application (2021–2026)
Table 61. Global HER2 ADC Drugs Sales (kg) by Application (2027–2032)
Table 62. Global HER2 ADC Drugs Sales Market Share by Application (2021–2026)
Table 63. Global HER2 ADC Drugs Sales Market Share by Application (2027–2032)
Table 64. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global HER2 ADC Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global HER2 ADC Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global HER2 ADC Drugs Price (US$/kg) by Application (2021–2026)
Table 69. Global HER2 ADC Drugs Price (US$/kg) by Application (2027–2032)
Table 70. Daiichi Sankyo Company Information
Table 71. Daiichi Sankyo Description and Business Overview
Table 72. Daiichi Sankyo HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Daiichi Sankyo HER2 ADC Drugs Product
Table 74. Daiichi Sankyo Recent Developments/Updates
Table 75. Genentech, Inc.(Roche) Company Information
Table 76. Genentech, Inc.(Roche) Description and Business Overview
Table 77. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Genentech, Inc.(Roche) HER2 ADC Drugs Product
Table 79. Genentech, Inc.(Roche) Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. AstraZeneca HER2 ADC Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. RemeGen Company Information
Table 86. RemeGen Description and Business Overview
Table 87. RemeGen HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. RemeGen HER2 ADC Drugs Product
Table 89. RemeGen Recent Developments/Updates
Table 90. MacroGenics Company Information
Table 91. MacroGenics Description and Business Overview
Table 92. MacroGenics HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. MacroGenics HER2 ADC Drugs Product
Table 94. MacroGenics Recent Developments/Updates
Table 95. Takeda Company Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Takeda HER2 ADC Drugs Product
Table 99. Takeda Recent Developments/Updates
Table 100. Biokin Pharmaceutical Company Information
Table 101. Biokin Pharmaceutical Description and Business Overview
Table 102. Biokin Pharmaceutical HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Biokin Pharmaceutical HER2 ADC Drugs Product
Table 104. Biokin Pharmaceutical Recent Developments/Updates
Table 105. BioNTech(Yingen Biopharmaceutical) Company Information
Table 106. BioNTech(Yingen Biopharmaceutical) Description and Business Overview
Table 107. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product
Table 109. BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
Table 110. CSPC Pharmaceutical Group Company Information
Table 111. CSPC Pharmaceutical Group Description and Business Overview
Table 112. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. CSPC Pharmaceutical Group HER2 ADC Drugs Product
Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
Table 115. Hengrui Pharmaceuticals Company Information
Table 116. Hengrui Pharmaceuticals Description and Business Overview
Table 117. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Hengrui Pharmaceuticals HER2 ADC Drugs Product
Table 119. Hengrui Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. HER2 ADC Drugs Distributors List
Table 123. HER2 ADC Drugs Customers List
Table 124. HER2 ADC Drugs Market Trends
Table 125. HER2 ADC Drugs Market Drivers
Table 126. HER2 ADC Drugs Market Challenges
Table 127. HER2 ADC Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of HER2 ADC Drugs
Figure 2. Global HER2 ADC Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global HER2 ADC Drugs Market Share by Type: 2025 & 2032
Figure 4. T-DM1（Kadcyla，Trastuzumab emtansine） Product Picture
Figure 5. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Product Picture
Figure 6. RC48（Disitamab vedotin） Product Picture
Figure 7. Global HER2 ADC Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global HER2 ADC Drugs Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Clinic
Figure 11. Others
Figure 12. Global HER2 ADC Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global HER2 ADC Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global HER2 ADC Drugs Sales (kg), 2021–2032
Figure 15. Global HER2 ADC Drugs Average Price (US$/kg), 2021–2032
Figure 16. HER2 ADC Drugs Report Years Considered
Figure 17. HER2 ADC Drugs Sales Share by Manufacturers in 2025
Figure 18. Global HER2 ADC Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global HER2 ADC Drugs Players: Market Share by Revenue in HER2 ADC Drugs in 2025
Figure 20. HER2 ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific HER2 ADC Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific HER2 ADC Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of HER2 ADC Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of HER2 ADC Drugs by Type (2021–2032)
Figure 55. Global HER2 ADC Drugs Price (US$/kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of HER2 ADC Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of HER2 ADC Drugs by Application (2021–2032)
Figure 58. Global HER2 ADC Drugs Price (US$/kg) by Application (2021–2032)
Figure 59. HER2 ADC Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global HER2 ADC Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global HER2 ADC Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global HER2 ADC Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global HER2 ADC Drugs Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global HER2 ADC Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global HER2 ADC Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market HER2 ADC Drugs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of HER2 ADC Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of HER2 ADC Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of HER2 ADC Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HER2 ADC Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on HER2 ADC Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global HER2 ADC Drugs Sales by Region (kg), 2021–2026
Table 18. Global HER2 ADC Drugs Sales Market Share by Region (2021–2026)
Table 19. Global HER2 ADC Drugs Sales by Region (kg), 2027–2032
Table 20. Global HER2 ADC Drugs Sales Market Share by Region (2027–2032)
Table 21. Global HER2 ADC Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global HER2 ADC Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global HER2 ADC Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global HER2 ADC Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 27. North America HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 28. North America HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 32. Europe HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 33. Europe HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific HER2 ADC Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific HER2 ADC Drugs Sales by Region (kg), 2021–2026
Table 37. Asia Pacific HER2 ADC Drugs Sales by Region (kg), 2027–2032
Table 38. Asia Pacific HER2 ADC Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific HER2 ADC Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 42. Latin America HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 43. Latin America HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa HER2 ADC Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa HER2 ADC Drugs Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa HER2 ADC Drugs Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa HER2 ADC Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa HER2 ADC Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global HER2 ADC Drugs Sales (kg) by Type (2021–2026)
Table 51. Global HER2 ADC Drugs Sales (kg) by Type (2027–2032)
Table 52. Global HER2 ADC Drugs Sales Market Share by Type (2021–2026)
Table 53. Global HER2 ADC Drugs Sales Market Share by Type (2027–2032)
Table 54. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global HER2 ADC Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global HER2 ADC Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global HER2 ADC Drugs Price (US$/kg) by Type (2021–2026)
Table 59. Global HER2 ADC Drugs Price (US$/kg) by Type (2027–2032)
Table 60. Global HER2 ADC Drugs Sales (kg) by Application (2021–2026)
Table 61. Global HER2 ADC Drugs Sales (kg) by Application (2027–2032)
Table 62. Global HER2 ADC Drugs Sales Market Share by Application (2021–2026)
Table 63. Global HER2 ADC Drugs Sales Market Share by Application (2027–2032)
Table 64. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global HER2 ADC Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global HER2 ADC Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global HER2 ADC Drugs Price (US$/kg) by Application (2021–2026)
Table 69. Global HER2 ADC Drugs Price (US$/kg) by Application (2027–2032)
Table 70. Daiichi Sankyo Company Information
Table 71. Daiichi Sankyo Description and Business Overview
Table 72. Daiichi Sankyo HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Daiichi Sankyo HER2 ADC Drugs Product
Table 74. Daiichi Sankyo Recent Developments/Updates
Table 75. Genentech, Inc.(Roche) Company Information
Table 76. Genentech, Inc.(Roche) Description and Business Overview
Table 77. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Genentech, Inc.(Roche) HER2 ADC Drugs Product
Table 79. Genentech, Inc.(Roche) Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. AstraZeneca HER2 ADC Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. RemeGen Company Information
Table 86. RemeGen Description and Business Overview
Table 87. RemeGen HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. RemeGen HER2 ADC Drugs Product
Table 89. RemeGen Recent Developments/Updates
Table 90. MacroGenics Company Information
Table 91. MacroGenics Description and Business Overview
Table 92. MacroGenics HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. MacroGenics HER2 ADC Drugs Product
Table 94. MacroGenics Recent Developments/Updates
Table 95. Takeda Company Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Takeda HER2 ADC Drugs Product
Table 99. Takeda Recent Developments/Updates
Table 100. Biokin Pharmaceutical Company Information
Table 101. Biokin Pharmaceutical Description and Business Overview
Table 102. Biokin Pharmaceutical HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Biokin Pharmaceutical HER2 ADC Drugs Product
Table 104. Biokin Pharmaceutical Recent Developments/Updates
Table 105. BioNTech(Yingen Biopharmaceutical) Company Information
Table 106. BioNTech(Yingen Biopharmaceutical) Description and Business Overview
Table 107. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product
Table 109. BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
Table 110. CSPC Pharmaceutical Group Company Information
Table 111. CSPC Pharmaceutical Group Description and Business Overview
Table 112. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. CSPC Pharmaceutical Group HER2 ADC Drugs Product
Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
Table 115. Hengrui Pharmaceuticals Company Information
Table 116. Hengrui Pharmaceuticals Description and Business Overview
Table 117. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Hengrui Pharmaceuticals HER2 ADC Drugs Product
Table 119. Hengrui Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. HER2 ADC Drugs Distributors List
Table 123. HER2 ADC Drugs Customers List
Table 124. HER2 ADC Drugs Market Trends
Table 125. HER2 ADC Drugs Market Drivers
Table 126. HER2 ADC Drugs Market Challenges
Table 127. HER2 ADC Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of HER2 ADC Drugs
Figure 2. Global HER2 ADC Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global HER2 ADC Drugs Market Share by Type: 2025 & 2032
Figure 4. T-DM1（Kadcyla，Trastuzumab emtansine） Product Picture
Figure 5. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Product Picture
Figure 6. RC48（Disitamab vedotin） Product Picture
Figure 7. Global HER2 ADC Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global HER2 ADC Drugs Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Clinic
Figure 11. Others
Figure 12. Global HER2 ADC Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global HER2 ADC Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global HER2 ADC Drugs Sales (kg), 2021–2032
Figure 15. Global HER2 ADC Drugs Average Price (US$/kg), 2021–2032
Figure 16. HER2 ADC Drugs Report Years Considered
Figure 17. HER2 ADC Drugs Sales Share by Manufacturers in 2025
Figure 18. Global HER2 ADC Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global HER2 ADC Drugs Players: Market Share by Revenue in HER2 ADC Drugs in 2025
Figure 20. HER2 ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific HER2 ADC Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific HER2 ADC Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa HER2 ADC Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa HER2 ADC Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE HER2 ADC Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of HER2 ADC Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of HER2 ADC Drugs by Type (2021–2032)
Figure 55. Global HER2 ADC Drugs Price (US$/kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of HER2 ADC Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of HER2 ADC Drugs by Application (2021–2032)
Figure 58. Global HER2 ADC Drugs Price (US$/kg) by Application (2021–2032)
Figure 59. HER2 ADC Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232